• 1. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 2. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 3. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 4. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 5. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan

Recent Advances in the Application of 3-(Bromomethyl)-2-nitropyridine (CAS: 15936-06-8) in Chemical Biology and Pharmaceutical Research

3-(Bromomethyl)-2-nitropyridine (CAS: 15936-06-8) is a versatile chemical intermediate that has garnered significant attention in recent years due to its applications in medicinal chemistry, drug discovery, and chemical biology. This heterocyclic compound, characterized by a reactive bromomethyl group and a nitro substituent, serves as a key building block for the synthesis of various bioactive molecules. Recent studies have explored its utility in developing novel kinase inhibitors, antimicrobial agents, and targeted covalent inhibitors, highlighting its importance in modern pharmaceutical research.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the use of 3-(Bromomethyl)-2-nitropyridine as a precursor for synthesizing potent and selective JAK3 inhibitors. The researchers utilized the bromomethyl group for efficient functionalization, enabling the creation of a diverse library of compounds with improved pharmacokinetic properties. This work underscores the compound's role in addressing the challenges of kinase inhibitor selectivity, a critical issue in autoimmune disease and cancer therapy.

In the field of antibacterial drug development, a recent breakthrough published in ACS Infectious Diseases (2024) reported the design of novel quinolone derivatives using 3-(Bromomethyl)-2-nitropyridine as a key intermediate. The resulting compounds showed remarkable activity against drug-resistant Gram-positive pathogens, with MIC values in the low micromolar range. The nitro group in particular was found to enhance bacterial membrane penetration, while the bromomethyl moiety allowed for strategic modifications to reduce cytotoxicity.

From a chemical biology perspective, innovative applications have emerged in protein labeling and targeted covalent modification. A Nature Chemical Biology paper (2023) described a novel bioconjugation strategy where 3-(Bromomethyl)-2-nitropyridine derivatives were engineered as electrophilic warheads for selective cysteine modification. This approach enabled precise mapping of protein-protein interaction interfaces and the development of activity-based probes for studying enzyme function in complex biological systems.

The synthetic versatility of 3-(Bromomethyl)-2-nitropyridine continues to expand, as evidenced by recent methodological advances. A 2024 Organic Letters publication presented a mild, transition-metal-free coupling protocol that preserves the sensitive nitro group while enabling diverse C-C bond formations. This development addresses previous limitations in handling this reactive intermediate and opens new possibilities for structure-activity relationship studies in drug discovery programs.

Looking forward, the unique reactivity profile of 3-(Bromomethyl)-2-nitropyridine positions it as a valuable tool for addressing emerging challenges in pharmaceutical research. Current investigations focus on its application in PROTAC (proteolysis targeting chimera) development and targeted protein degradation strategies, where its dual functionality offers distinct advantages for linker design. As research progresses, this compound is expected to play an increasingly important role in the development of next-generation therapeutics and chemical probes.

• 8015-91-6(Cinnamon Bark Oil)
• 114042-02-3(5-Bromo-3-methyl-2-nitropyridine)
• 65169-29-1(3,4-dimethyl-2-nitro-Pyridine)
• 65169-41-7(Pyridine,3,5-dimethyl-2-nitro-)
• 73545-02-5(QUINOLINE, METHYLNITRO-)
• 5175-26-8(2-nitropyridine-3-carbaldehyde)
• 18368-73-5(3-Methyl-2-nitropyridine)
• 1074-38-0(5-methyl-2-nitro-pyridine)
• 65169-52-0(Pyridine,3,6-dimethyl-2-nitro-)
• 448968-52-3(5-(bromomethyl)-2-nitroPyridine)